Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,863 | 225 | 95.2% |
| Education | $243.06 | 6 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $735.72 | 21 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $674.91 | 21 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $644.93 | 39 | $0 (2023) |
| Allergan, Inc. | $492.33 | 32 | $0 (2021) |
| ABBVIE INC. | $445.52 | 26 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $425.98 | 29 | $0 (2020) |
| Vanda Pharmaceuticals Inc. | $349.61 | 13 | $0 (2023) |
| Lundbeck LLC | $236.99 | 12 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $172.62 | 7 | $0 (2019) |
| Merck Sharp & Dohme LLC | $164.60 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $212.34 | 5 | Alkermes, Inc. ($198.48) |
| 2023 | $303.35 | 10 | Alkermes, Inc. ($116.89) |
| 2022 | $724.30 | 34 | Otsuka America Pharmaceutical, Inc. ($158.24) |
| 2021 | $693.27 | 40 | AbbVie Inc. ($249.17) |
| 2020 | $366.03 | 21 | Allergan, Inc. ($200.40) |
| 2019 | $1,115 | 50 | Teva Pharmaceuticals USA, Inc. ($222.34) |
| 2018 | $1,058 | 49 | Teva Pharmaceuticals USA, Inc. ($272.58) |
| 2017 | $635.00 | 22 | Otsuka America Pharmaceutical, Inc. ($139.70) |
All Payment Transactions
231 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $75.64 | General |
| Category: CNS | ||||||
| 05/30/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: CNS | ||||||
| 03/26/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Neuroscience | ||||||
| 03/14/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $97.60 | General |
| Category: CNS | ||||||
| 01/10/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: CNS | ||||||
| 11/16/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: CNS | ||||||
| 06/06/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: CNS | ||||||
| 05/23/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $31.70 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 04/26/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 04/19/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: PSYCHIATRY | ||||||
| 04/18/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $31.70 | General |
| Category: Neuroscience | ||||||
| 02/23/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $80.14 | General |
| Category: CNS | ||||||
| 02/06/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 01/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/28/2022 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/21/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/14/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $30.06 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/17/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.28 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 88 | 360 | $75,580 | $18,834 |
| 2022 | 2 | 72 | 536 | $94,580 | $24,559 |
| 2021 | 3 | 88 | 583 | $104,010 | $35,962 |
| 2020 | 3 | 91 | 480 | $86,065 | $27,063 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 188 | $40,130 | $10,386 | 25.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 32 | 104 | $19,510 | $4,377 | 22.4% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 21 | 68 | $15,940 | $4,071 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 284 | $45,440 | $13,579 | 29.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 36 | 252 | $49,140 | $10,980 | 22.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 291 | $46,560 | $19,880 | 42.7% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 37 | 275 | $53,625 | $14,887 | 27.8% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 13 | 17 | $3,825 | $1,195 | 31.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 38 | 241 | $38,560 | $13,410 | 34.8% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 37 | 209 | $40,755 | $11,643 | 28.6% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 16 | 30 | $6,750 | $2,010 | 29.8% |
About Dr. Victor Richenstein, MD
Dr. Victor Richenstein, MD is a Psychiatry healthcare provider based in Eugene, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205811502.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Victor Richenstein, MD has received a total of $5,106 in payments from pharmaceutical and medical device companies, with $212.34 received in 2024. These payments were reported across 231 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($4,863).
As a Medicare-enrolled provider, Richenstein has provided services to 339 Medicare beneficiaries, totaling 1,959 services with total Medicare billing of $106,418. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Eugene, OR
- Active Since 12/08/2005
- Last Updated 04/06/2011
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205811502
Products in Payments
- VRAYLAR (Drug) $935.85
- AUSTEDO (Drug) $515.92
- LATUDA (Drug) $425.98
- REXULTI (Drug) $415.30
- LYBALVI (Drug) $353.58
- HETLIOZ (Drug) $241.24
- Aristada 441 mg (Drug) $209.47
- ABILIFY MAINTENA (Drug) $205.94
- ARISTADA (Drug) $172.67
- INGREZZA (Drug) $172.62
- ABILIFY MYCITE (Drug) $166.73
- BELSOMRA (Drug) $164.60
- TRINTELLIX (Drug) $148.05
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $123.33
- FANAPT (Drug) $108.37
- CAPLYTA (Drug) $98.84
- MYDAYIS (Drug) $76.70
- INVEGA SUSTENNA (Drug) $72.02
- Trintellix (Drug) $56.58
- SPRAVATO (Drug) $45.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Eugene
Dr. John Lipkin, M.d, M.D
Psychiatry — Payments: $15,260
Dr. Hernan Schmidt, M.d, M.D
Psychiatry — Payments: $6,567
Veronica Alfero, Md, MD
Psychiatry — Payments: $2,017
Dr. Franc Strgar, M.d, M.D
Psychiatry — Payments: $1,445
Dr. Russell Geoffrey, Md, MD
Psychiatry — Payments: $1,378
Dr. Harold Whiteley, M.d, M.D
Psychiatry — Payments: $1,215